ANOTHER candidate cervical cancer vaccine that is currently awaiting approval in the United States and in other countries is GlaxoSmithKline’s bivalent vaccine.
This vaccine contains the two types of HPV that typically cause cancer: 16 and 18.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!